Canada has a chance to lead on AI policy and data governance at the 2025 G7 Leaders' Summit

Yahoo

4 days ago

Artificial intelligence (AI) is rapidly transforming sectors from health care to climate science. But amid the global scramble to lead this technological revolution, one truth is becoming clearer: data, its platforms and its circulations, have become critical infrastructure. And Canada, poised to host this year's G7 Leaders Summit, has a rare opportunity to shape the rules that will govern AI globally.
Under the leadership of Prime Minister Mark Carney, the federal government elevated AI and digital innovation to a central pillar of national policy, and appointed Evan Solomon as minister of artificial intelligence and digital innovation. But ambition is not enough — Canada must now back its rhetoric with action that resonates at home and abroad.
While AI headlines often focus on breakthroughs in generative models and robotics, the real engine of progress lies in less glamorous terrain: computing infrastructure and data systems.
Canada's proposal to build 'next-generation data centres' is about creating the backbone for globally competitive and ethically governed AI. Without these facilities, modern AI systems cannot be trained, validated or deployed responsibly.
AI models — like those used in medicine for developing new drugs and health services, clean technologies such as clean energy and carbon-capture or materials science — require enormous computational power and massive datasets. That data must be structured, validated and — to the extent possible — open to those who can use it.
Our recent study underscores that the future of AI depends less on algorithmic cleverness and more on data quality and accessibility. Poorly labelled or fragmented datasets can introduce bias, reduce model performance or even endanger lives when used in health or safety applications.
Yet across many domains, useful data remains siloed and locked in proprietary formats, lacking documentation or inaccessible due to legal and technical barriers. This status quo serves monopolies, not society.
Canada holds the G7 presidency in 2025, and can provide leadership in data governance and AI innovation. A central priority should be to rally partners around a framework for ethical, accessible and well-designed datasets, especially in fields like health, climate science and materials research.
Our call for open data isn't one-size-fits-all. It must be tailored to the needs of specific sectors:
Health-care AI requires anonymized patient data, genomic sequences, protein structure data, toxicology and carcinogen data, and drug response datasets.
Climate AI needs long-term environmental records, satellite imagery, power and water use information and real-time emissions data.
Materials science AI demands chemical interaction data, physical testing results, structural data and thermodynamic properties.
What binds these fields is a common challenge: ensuring data is ethically sourced, high-quality, and useable across borders and institutions. Canada's role should be to help build the platforms — digital, legal and diplomatic — that make this possible.
As host of the G7 in June, Canada can push for a transformative international commitment. At a minimum, this should include:
Common standards for open datasets, co-designed with input from AI developers, health professionals, climate researchers, materials scientists and legal experts.
Trusted data hubs, managed by public-private or non-profit entities, ensuring secure storage, privacy safeguards and public access.
Legal and diplomatic co-ordination, addressing cross-border data sharing, intellectual property constraints and ethical governance frameworks.
These steps would position the G7 — and Canada in particular — as a champion of AI that serves democratic values on top of commercial and geopolitical interests.
Canada is not starting from scratch. The country boasts leading AI research institutions, including the Vector Institute and Mila, and has pioneered open science partnerships such as the Montreal Neurological Institute's Tanenbaum Open Science Institute and the Toronto labs of the Structural Genomics Consortium.
Dataset platforms such as AIRCHECK(for AI-based chemical knowledge) and the CACHE competition (evaluating drug discovery models using open data), show how Canada is already putting together the building blocks of responsible AI. But the country risks squandering this advantage if it cannot scale these efforts or retain innovation domestically.
The stalled Artificial Intelligence and Data Act is a case in point. While the European Union moved forward with its AI Act, the General Data Protection Regulation and the European Health Data Space Regulation, Canada's legislative framework remains in flux.
Without clear domestic rules, and a proactive global agenda, Canada could end up as an incubator for innovations that end up developed and applied elsewhere.
The AI race is not just about who builds the most powerful models. It's about who defines the technical, ethical and geopolitical standards that shape the digital future.
The G7 offers Canada a moment of strategic clarity. By investing in AI infrastructure and leading an international agenda on open, trustworthy AI, Canada can lead in shaping the rules.
This article is republished from The Conversation, a nonprofit, independent news organisation bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: E. Richard Gold, McGill University and Cristina Vanberghen, European University Institute
Read more:
Regulating AI seems like an impossible task, but ethically and economically, it's a vital one
The robot revolution is here: How it's changing jobs and businesses in Canada
An international body will need to oversee AI regulation, but we need to think carefully about what it looks like
E. Richard Gold receives funding from TRIDENT: TRanslational Initiative to DE-risk NeuroTherapeutics, a project funded by the New Frontiers in Research Fund, application NFRFT-2022-00051. Gold is also the Chief Policy and Partnerships Officer of Conscience, a Canadian non-profit focused on enabling drug discovery and development in areas where open sharing and collaboration are key to advancement and where market solutions are limited, such as rare or neglected diseases, pandemic preparedness, and antimicrobial resistance.
Cristina Vanberghen does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.